Parkinson’s clinical trial gets fast tracked
A drug commonly used to treat liver disease holds promise in slowing down progression of Parkinson’s disease. The discovery comes from scientists at the University of Sheffield. The findings have put the drug – ursodeoxycholic acid (UDCA) – on the fast track for clinical trials in Parkinson’s patients. Parkinson’s UK Senior Research Fellow, Dr. Heather ...click here to read more
